WO2026083295 - TRISPECIFIC COMPOSITIONS COMPRISING IL-2, VEGF BINDING DOMAINS, AND PD-1 BINDING DOMAINS
National phase entry is expected:
Publication Number
WO/2026/083295
Publication Date
23.04.2026
International Application No.
PCT/IB2025/060508
International Filing Date
15.10.2025
Title **
[English]
TRISPECIFIC COMPOSITIONS COMPRISING IL-2, VEGF BINDING DOMAINS, AND PD-1 BINDING DOMAINS
[French]
COMPOSITIONS TRISPÉCIFIQUES COMPRENANT IL-2, DES DOMAINES DE LIAISON AU VEGF ET DES DOMAINES DE LIAISON À PD-1
Applicants **
BRIGHT PEAK THERAPEUTICS AG
Inventors
PATTABIRAMAN, Vijaya Raghavan
KREFT, Bertolt
GOEPFERT, Arnaud
MARTIN, Kea
BORNERT, Olivier
RESCHKE, Nina
Priority Data
63/708,077
16.10.2024
US
63/739,330
27.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 10404 | |
| EPO | Filing, Examination, Granting | 234978 | |
| Japan | Filing, Examination, Granting | 5545 | |
| South Korea | Filing, Examination, Granting | 13768 | |
| USA | Filing, Examination, Granting | 47090 |
Total:
311,785
Contact Us
Abstract[English]
The present disclosure relates anti-PD-1/anti-VEGF immunocytokines, particularly with IL-2. Also described herein are bispecific anti-PD-1 and anti-VEGF constructs. IL-2 polypeptides are also provided herein. Also provided herein are pharmaceutical compositions and methods of treatment using the aforementioned compositions.[French]
La présente divulgation concerne des immunocytokines anti-PD-1/anti-VEGF, notamment avec IL-2. Sont également décrites des constructions bispécifiques anti-PD-1 et anti-VEGF. La divulgation concerne également des polypeptides d'IL-2. L'invention concerne également des compositions pharmaceutiques et des méthodes de traitement utilisant lesdites compositions.